Andy Smith sat comfortably in the passenger seat of his parentsâ blue Toyota SUV, his head leaning back against the headrest with thoughts on how Jan. 12 would be spent simply relaxing at home after an unplanned trip to the Front Range.
Once the car pulled up to the house, however, he quickly noticed a crowd â neighbors, family, some of his old Grand Junction High School basketball teammates and even the GJHS Tigersâ mascot â waiting outside with balloons and signs.
It was a triumphant welcome home party for a young man who had spent 50 nights away because of a brain tumor which, in jest, he dubbed âBenji.â Those 50 nights were marked by challenges, concern and cameos by the all-time winningest coach in menâs college basketball, but more on that later.
Ultraviolet (UV) radiation is hard to understand because you can't see it or feel it, but it can still damage your skin and causes 95% of skin cancers in.
Radiation criteria sow confusion for evacuees Sorry, but your browser needs Javascript to use this site. If you re not sure how to activate it, please refer to this site: https://www.enable-javascript.com/
Workers decontaminate a road in a special reconstruction district in the town of Futaba, Fukushima Prefecture, in October. | FUKUSHIMA MINPO
Fukushima Minpo Feb 26, 2021
Traffic was lighter on the Joban Expressway in the Futaba district in Fukushima Prefecture during the New Year holiday, with people avoiding traveling back to see their relatives due to the novel coronavirus pandemic.
Roadside signs show the radiation levels of areas near the no-go zones put in place after meltdowns in 2011 at the Fukushima No. 1 nuclear plant, reflecting the fact that, even after 10 years, Fukushima residents are unable to return to their homes.
TOKYO, Feb 26, 2021 - (JCN Newswire) - Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically
Sirtex Medical receives positive recommendation from National Institute for Health and Care Excellence (NICE) for selective internal radiation therapy (SIRT) using SIR-Spheres
WOBURN, Mass., Feb. 26, 2021 /PRNewswire/
Sirtex Medical US Holdings, Inc. ( Sirtex ), a leading manufacturer of targeted cancer therapies, received positive guidance from the National Institute for Health and Care Excellence (NICE) regarding the use of selection internal radiation therapy (SIRT) with SIR-Spheres Y-90 microspheres for the treatment of adults with unresectable advanced hepatocellular carcinoma (HCC).
NICE recommends the use of SIRT using SIR-Spheres in England and Wales as a fully funded and reimbursed option for adult patients with HCC, on the conditions that it is used for people with Child-Pugh grade A liver impairment when conventional transarterial therapies are inappropriate, and that the company provides SIR-Spheres according to the commercial arrangement.